): This is a competing application for renewal of a postdoctoral training grant in molecular virology and oncology that is currently in Year 20. Eight slots per year are requested for individuals with the Ph.D., M.D., or M.D./Ph.D. degree. The principal goal of the program is to provide an intensive two-year laboratory research experience under the direct supervision of one of the participating faculty in order to prepare the trainees for a career in independent basic cancer research. Trainees are also expected to attend courses in cancer and biomedical ethics and to gain experience in presenting their work. The investigators comprising the faculty are drawn from numerous departments at Yale and share a common interest in using molecular genetic approaches to obtain a mechanistic molecular understanding of oncogenesis, with a particular emphasis on the interactions between tumor viruses and cells. A number of the faculty participate in a Program Project Grant on Viral Transformation that was recently renewed for a five year period. In addition to their related individual research interests, the investigators are linked by numerous collaborative projects, frequent informal consultations, discussions, sharing of materials and participation in joint research seminars, journal clubs and teaching activities. To ensure the continued vitality and success of this training program, several outstanding new faculty have been recruited who share a research interest in the molecular mechanisms of carcinogenesis. These new trainers focus on aspects of cell cycle control, signal transduction, transcriptional regulation, and genome instability. The Program Director, Daniel DiMaio, M.D., Ph.D., Professor of Genetics, devotes his laboratory effort to the study of papillomaviruses and their effects on cell growth. He is also the Principal Investigator of the Program Project Grant, 'Molecular Basis of Viral Transformation' and the Director of the Molecular Virology Program of the Yale Comprehensive Cancer Center. In these capacities, he is well positioned to foster interactions among other members of the faculty in the School of Medicine and the Faculty of Arts and Sciences.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
2T32CA009159-21
Application #
2084959
Study Section
Cancer Research Manpower and Education Review Committee (CRME)
Project Start
1980-07-01
Project End
2001-08-31
Budget Start
1996-09-12
Budget End
1997-08-31
Support Year
21
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Yale University
Department
Genetics
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Crosby, Meredith E; Kulshreshtha, Ritu; Ivan, Mircea et al. (2009) MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res 69:1221-9
Zito, Christina I; Riches, David; Kolmakova, Julia et al. (2008) Direct resequencing of the complete ERBB2 coding sequence reveals an absence of activating mutations in ERBB2 amplified breast cancer. Genes Chromosomes Cancer 47:633-8
Bhaduri-McIntosh, Sumita; Rotenberg, Marisa J; Gardner, Benjamin et al. (2008) Repertoire and frequency of immune cells reactive to Epstein-Barr virus-derived autologous lymphoblastoid cell lines. Blood 111:1334-43
Conrad, Nicholas K; Shu, Mei-Di; Uyhazi, Katherine E et al. (2007) Mutational analysis of a viral RNA element that counteracts rapid RNA decay by interaction with the polyadenylate tail. Proc Natl Acad Sci U S A 104:10412-7
Bhaduri-McIntosh, Sumita; Landry, Marie L; Nikiforow, Sarah et al. (2007) Serum IgA antibodies to Epstein-Barr virus (EBV) early lytic antigens are present in primary EBV infection. J Infect Dis 195:483-92
Conrad, Nicholas K; Mili, Stavroula; Marshall, Eleanor L et al. (2006) Identification of a rapid mammalian deadenylation-dependent decay pathway and its inhibition by a viral RNA element. Mol Cell 24:943-53
Paintsil, Elijah; Margolis, Asa; Collins, Jennifer A et al. (2006) The contribution of HIV fitness to the evolution pattern of reverse transcriptase inhibitor resistance. J Med Virol 78:425-30
Conrad, N K; Fok, V; Cazalla, D et al. (2006) The challenge of viral snRNPs. Cold Spring Harb Symp Quant Biol 71:377-84
Bhaduri-McIntosh, Sumita; Miller, George (2006) Cells lytically infected with Epstein-Barr virus are detected and separable by immunoglobulins from EBV-seropositive individuals. J Virol Methods 137:103-14
Collins, Jennifer A; Thompson, M Gregory; Paintsil, Elijah et al. (2004) Competitive fitness of nevirapine-resistant human immunodeficiency virus type 1 mutants. J Virol 78:603-11

Showing the most recent 10 out of 35 publications